179170-56-0

Basic information

• Product Name: 4-(2-(2-phenyl-4-oxazolyl)ethoxy)-benzaldehyde
• Synonyms: 4-(2-(2-phenyl-4-oxazolyl)ethoxy)-benzaldehyde
• CAS NO: 179170-56-0
• Molecular Weight: 293.322
• Mol File: 179170-56-0.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 4-(2-(2-phenyl-4-oxazolyl)ethoxy)-benzaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(2-(2-phenyl-4-oxazolyl)ethoxy)-benzaldehyde(179170-56-0)
• EPA Substance Registry System: 4-(2-(2-phenyl-4-oxazolyl)ethoxy)-benzaldehyde(179170-56-0)

Safety Data

• Hazardous Substances Data: 179170-56-0(Hazardous Substances Data)

Upstream product

• 123-08-0 4-hydroxy-benzaldehyde 
• 173173-54-1 2-(2-phenyloxazol-4-yl)-ethanol 
• 201660-21-1 2-(2-phenyl-4-oxazolyl)ethyl methanesulfonate 
• 425381-67-5 methyl (2-phenyloxazol-4-yl)acetate 
• 55-21-0 benzamide 
• 22086-89-1 (2-phenyloxazol-4-yl)acetic acid 

Downstream Products

• 201660-23-3 O-[4-[2-(2-phenyl-4-oxazolyl)ethoxy]phenylmethyl]-N-triphenylmetyl-L-serine methyl ester 
• 201660-24-4 N-benzyloxycarbonyl-O-[4-[2-(2-phenyl-4-oxazolyl)ethoxy]phenylmethyl]-L-serine methyl ester 
• 201660-22-2 4-[2-[4-(bromomethyl)phenoxy]ethyl]-2-phenyloxazole 
• 179170-38-8 4-[2-(2-Phenyl-4-oxazolyl)-ethoxy]phenylmethanol 

Relevant articles and documents

HETEROCYCLIC CARBOXYLIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITION FOR INHIBITING LIPID ACCUMULATION CONTAINING SAME

The present invention relates to a novel heterocyclic carboxylic acid derivative, or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the same as an active ingredient for inhibiting the accumulation of lipids in the body.

Hypoglycemic and hypolipidemic compounds

This invention provides compounds and their pharmaceutically-acceptable salts, pharmaceutical formulations of said compounds, and methods for treating hyperglycemia associated with non-insulin dependent diabetes and for treating hyperlipidemia.

Azole phenoxy hydroxyureas as selective and orally active inhibitors of 5- lipoxygenase

Azole phenoxy hydroxyureas are a new class of 5-lipoxygenase (5-LO) inhibitors. Structure-activity relationship studies have demonstrated that electronegative substituents on the 2-phenyl portion of the oxazole tail increased the ex vivo potency of these